P3 Health Partners Inc.

Equities

PIII

US7444131053

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
0.501 USD +0.18% Intraday chart for P3 Health Partners Inc. -15.85% -64.47%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BTIG Research Downgrades P3 Health Partners to Neutral From Buy MT
Transcript : P3 Health Partners Inc., Q4 2023 Earnings Call, Mar 28, 2024
P3 Health Partners Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q4 Revenue $346.9M, vs. Street Est of $302.7M MT
P3 Health Partners Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024 CI
Lake Street Adjusts Price Target on P3 Health Partners to $4.50 From $9, Maintains Buy Rating MT
Transcript : P3 Health Partners Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01:30 PM
Global markets live: J Sainsbury, Intel, Tesla, Boeing, Amazon... Our Logo
P3 Health Partners Reaffirms 2023 Revenue Guidance, Issues 2024 Outlook MT
In wait-and-see mode Our Logo
P3 Health Partners Inc. Reaffirms Earnings Guidance for the Year Ended December 31, 2023 and Provides Earnings Guidance for the Year Ending December 31, 2024 CI
Transcript : P3 Health Partners Inc., Q3 2023 Earnings Call, Nov 08, 2023
Earnings Flash (PIII) P3 HEALTH PARTNERS Posts Q3 Revenue $288.4M, vs. Street Est of $293.3M MT
P3 Health Partners Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
P3 Health Partners Inc. Provides Earnings Guidance for the Year 2023 CI
BTIG Initiates P3 Health Partners With Buy Rating, Price Target is $5 MT
Transcript : P3 Health Partners Inc., Q2 2023 Earnings Call, Aug 07, 2023
Earnings Flash (PIII) P3 HEALTH PARTNERS Reports Q2 Revenue $329.1M, vs. Street Est of $303.3M MT
P3 Health Partners Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
P3 Health Partners Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2023 CI
TD Cowen Initiates P3 Health Partners at Market Perform MT
P3 Health Partners Inc.(NasdaqCM:PIII) dropped from Russell 2500 Value Index CI
P3 Health Partners Inc.(NasdaqCM:PIII) dropped from Russell Small Cap Comp Value Index CI
P3 Health Partners Inc.(NasdaqCM:PIII) added to Russell 3000E Index CI
Chart P3 Health Partners Inc.
More charts
P3 Health Partners Inc. is a patient-centered and physician-led population health management company. The Company supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, it creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. Its technology platform, P3 Technology/Health Hub, enables physicians, care teams, patients and their family members to engage in the care journey. P3 Technology/Health Hub integrates clinical and claims data from more than 250 disparate data points each month from payors, outpatient and inpatient facilities and other ancillary care settings. It has a network of more than 2,800 affiliated primary care providers across the country. Its local teams of health care professionals manage the care of thousands of patients in 23 counties across five states.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
0.501 USD
Average target price
3.467 USD
Spread / Average Target
+591.95%
Consensus
  1. Stock Market
  2. Equities
  3. PIII Stock
  4. News P3 Health Partners Inc.
  5. P3 Health Partners Appoints Atul Kavthekar Chief Financial Officer